Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Elsevier<%2Fa>,%20a%20world-leading%20provider%20of%20scientific,%20technical%20and%20medical%20information%20products%20and%20services,%20announced%20today%20the%20acquisition%20of InferMed<%2Fa>,%20a%20London-based%20clinical%20decision%20support%20(CDS)%20technology%20company.%0D%0A%0D%0Ahttps%3A%2F%2Fwww.bookbusinessmag.com%2Farticle%2Felsevier-acquires-infermed-provider-clinical-decision-support-technology%2F" target="_blank" class="email" data-post-id="19565" type="icon_link">
Email
Email
0 Comments
Comments
"Clinicians are overloaded with sometimes distracting materials, so they still very much need the right, evidence-based information at the right time in order to choose the most appropriate treatment for each patient," said Robert Dunlop, Clinical Director at InferMed. "Arezzo only offers information that's pertinent to the case in hand, yet the complete guideline remains in the background should complex cases demand little-used pathways.
0 Comments
View Comments
- People:
- Jay Katzen
- Robert Dunlop
- Places:
- London
- PHILADELPHIA, PA
- UK
Related Content
Comments